Evidence map›Paper›PMID 40994666›Full record

ArticleStructural heart : the journal of the Heart Team2025

Computed Tomography-Based Evaluation of Redo-Transcatheter Aortic Valve Replacement Feasibility for Self-Expanding Valves.

Yusuke Kobari, Arif A Khokhar, Davorka Lulic, Klaus Fuglsang Kofoed, Andreas Fuchs, Gintautas Bieliauskas, Sahil Khera, Gilbert Hl Tang, Ole De Backer

Abstract read
In one paragraph

Article in Structural heart : the journal of the Heart Team, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yusuke KobariDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.
Arif A KhokharDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.
Davorka LulicDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.
Klaus Fuglsang KofoedDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.
Andreas FuchsDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.
Gintautas BieliauskasDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.
Sahil KheraMount Sinai Fuster Heart Hospital, New York, New York, USA.
Gilbert Hl TangMount Sinai Fuster Heart Hospital, New York, New York, USA.
Ole De BackerDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Redo-transcatheter aortic valve replacement (TAVR) may be unfeasible due to the risk of coronary flow compromise by the pinned-back leaflets of the index transcatheter aortic valve (TAV). This study aimed to evaluate the feasibility of redo-TAVR using a balloon-expandable SAPIEN 3 (S3, Edwards Lifesciences, USA) implanted within the intra-annular self-expanding Navitor TAV (Abbott, USA). Methods: A total of 106 post-TAVR computed tomography scans of patients who underwent Navitor implantation were analyzed. Redo-TAVR using an S3 was simulated in 2 positions: S3 outflow to node 2 of the Navitor (low implant) and S3 outflow to the base of the Navitor commissural posts (high implant). The overall coronary risk, determined by the risk of coronary flow compromise and coronary inaccessibility, was determined by the height of the neoskirt plane and the valve-to-aorta distances. Results: At a low S3 implant position, the overall coronary risk was high for only 1% of patients, but this increased to 39% with a high S3 implant position. If the high S3 implant was combined with a high index Navitor implant depth, 73% of patients were deemed high coronary risk, which could be reduced to 28% in case of an index Navitor implant depth >5 mm. At both S3 implant depths, redo-TAVR in Navitor was associated with a lower coronary risk compared to redo-TAVR in supra-annular self-expanding valves. Conclusions: The feasibility of redo-TAVR following S3-in-self-expanding valve depends on the type and implant depth of the index TAV as well as the implant depth of the second TAV.

Indexed as

Aortic stenosisComputed tomographyLifetime managementReinterventionTranscatheter aortic valve replacement

Identifiers

PMID40994666
PMCPMC12455090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.